parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Item

http://www.wikidata.org/entity/Q42784718

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@en

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@nl

type

Item

label

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@en

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@nl

prefLabel

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@en

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

@nl

P1476

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513

@en

P2093

Marc Galimand

http://www.w3.org/2001/XMLSchema#string

Patrice Courvalin

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of group A streptococcal infections

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.

Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance

Group A streptococci in the 1990s.

Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae

Isolation of transformation-deficient Streptococcus pneumoniae mutants defective in control of competence, using insertion-duplication mutagenesis with the erythromycin resistance determinant of pAM beta 1

Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.

P304

3686-3687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.11.3686-3687.2002

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo Alonso

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12384394

http://www.w3.org/2001/XMLSchema#string

P932

128750

http://www.w3.org/2001/XMLSchema#string